Geneva, Switzerland - June 30, 2025 - Addex Therapeutics (SIX: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for ...

Geneva--(Marketwired - May 31, 2013) - Addex Therapeutics / Addex Completes Restructuring to Focus on Capturing Potential Upside from its Partnered Asset and CEO Steps Down Processed and transmitted ...

Launched Neurosterix with Perceptive Advisors, raising USD 65 million in Series A to advance preclinical portfolio Indivior selected GABAB PAM drug candidate and started IND enabling studies for ...

Allosteric modulation company Addex Pharmaceuticals Ltd (Swiss:ADXN - News) announced today that Vincent Mutel, PhD, has stepped down from his position as CEO of the Addex group. Mr. André J. Mueller, ...

Geneva, Switzerland, March 24, 2022-Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Addex Therapeutics Ltd. Sponsored ADR (ADXN) been one of those stocks this year?

Geneva, Switzerland - June 30, 2025 - Addex Therapeutics(SIX: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for ...